Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma

Autor: Omar Alhalabi, Matthew T. Campbell, Lianchun Xiao, Ana C. Adriazola, Nathaniel R. Wilson, Arlene O. Siefker‐Radtke, Paul G. Corn, Amado Zurita, Eric Jonasch, Jianjun Gao, Mehrad Adibi, Ashish M. Kamat, Neema Navai, Louis L. Pisters, Colin Dinney, Surena F. Matin, Amishi Y. Shah

Publikováno v: BJUI Compass, Vol 3, Iss 1, Pp 37-44 (2022)

Abstract Objectives Multimodal kidney‐preserving (MKP) strategies may be an option for patients with localised or locally advanced high‐risk upper tract urothelial carcinoma (UTUC) who have a relative contraindication for nephroureterectomy (NU).

Externí odkaz: https://doaj.org/article/4bec1710d1984582ada90fc20a09d76b

Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events

Autor: Jennifer Wang, Jianjun Gao, Pavlos Msaouel, Padmanee Sharma, Nizar Tannir, Sumit K Subudhi, Eric Jonasch, Amishi Shah, Matthew T Campbell, Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, Tharakeswara K Bathala, Devaki Shilpa Surasi, Sangeeta Goswami, Amado J Zurita, Paul G Corn, Ana M Aparicio, Arlene O Siefker-Radtke

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)

Background Immune checkpoint therapy (ICT) prolongs survival in subsets of patients with cancer but can also trigger immune-related adverse events (irAEs) requiring treatment discontinuation. Recent studies have investigated safety of ICT rechallenge

Externí odkaz: https://doaj.org/article/cda99109c2c04a0cb9747cd3f91c2b17

NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022

Autor: Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Kevin Chan, Sam Chang, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman-Censits, Amar Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Vitaly Margulis, Omar Y. Mian, Jeff Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Mamta Parikh, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Kyle Richards, Wade J. Sexton, Arlene O. Siefker-Radtke, Matthew Tollefson, Jonathan Tward, Jonathan L. Wright, Mary A. Dwyer, Carly J. Cassara, Lisa A. Gurski

Publikováno v: Journal of the National Comprehensive Cancer Network. 20:866-878

The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer and other urinary tract cancers (upper tract tumors, urothelial carcinoma of the prostate, primary

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29ccac59f986db25b0b2110e96aea8b9
https://doi.org/10.6004/jnccn.2022.0041

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

Autor: A. S. Feils, A. K. Erbe, J. Birstler, K. Kim, U. Hoch, S. L. Currie, T. Nguyen, D. Yu, A. O. Siefker-Radtke, N. Tannir, S. M. Tolaney, A. Diab, P. M. Sondel

Publikováno v: Cancer Immunology, Immunotherapy.

Bempegaldesleukin (BEMPEG), a CD122-preferential IL2 pathway agonist, has been shown to induce proliferation and activation of NK cells. NK activation is dependent on the balance of inhibitory and excitatory signals transmitted by NK receptors, inclu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::219f2e38434efb5aa9923915f90abcb4
https://doi.org/10.1007/s00262-023-03383-w

Contributors

Autor: Eddie K. Abdalla, Jitesh Ahuja, Felipe Aluja-Jaramillo, Rodabe N. Amaria, Behrang Amini, Anca Avram, Rony Avritscher, Isabelle Bedrosian, Sonia L. Betancourt-Cuellar, Priya R. Bhosale, Andrew J. Bishop, Yulia Bronstein, Constantine M. Burgan, Hop S. Tran Cao, Sudpreeda Chainitikun, Joe Y. Chang, Lisly J.Chery, Hubert H. Chuang, Aaron Coleman, Colleen M. Costelloe, Prajnan Das, Reordan DeJesus, Catherine Devine, Patricia J. Eifel, Jeremy J. Erasmus, Silvana C.Faria, Jason B. Fleming, Samuel J. Galgano, Dhakshinamoorthy Ganeshan, Naveen Garg, Patrick B. Garvey, Gregory Gladish, Chunxiao Guo, Fernando R. Gutiérrez, Daniel M. Halperin, Abdelrahman K. Hanafy, Karen Hoffman, Wayne L. Hofstetter, Wen-Jen Hwu, Juan J. Ibarra Rovira, Mohannad Ibrahim, Naruhiko Ikoma, Revathy B. Iyer, Sanaz Javadi, Milind Javle, Corey T. Jensen, Eric Jonasch, Aparna Kamat, Ashish Kamat, Avinash R. Kambadakone, Gregory P. Kaufman, Amritjot Kaur, Harmeet Kaur, Brinda Rao Korivi, Rajendra Kumar, Vikas Kundra, Marcelo F. Kuperman Benveniste, Ott Le, Jeffrey H. Lee, Huang LePetross, Patrick P. Lin, Joseph A. Ludwig, Homer A. Macapinlac, John E. Madewell, Paul Mansfield, Leonardo P. Marcal, Edith M. Marom, Tara Massini, Aurelio Matamoros, Mary Frances McAleer, Reza J. Mehran, Christine Menias, Ajaykumar C. Morani, Van K. Morris, Stacy L. Moulder-Thompson, Bilal Mujtaba, Suresh K. Mukherji, Sameh Nassar, Quynh-Nhu Nguyen, Yoshifumi Noda, Amir Onn, Michael J. Overman, Lance C. Pagliaro, Diana P. Palacio, Anushri Parakh, Hemant A. Parmar, Shreyaskumar Patel, Madhavi Patnana, Alexandria Phan, Halyna Pokhylevych, Kristin K. Porter, Gaiane M. Rauch, Bharat Raval, Miguel Rodriguez-Bigas, Eric M. Rohren, Christina L. Roland, Jeremy Ross, Bradley S. Sabloff, Tara Sagebiel, Dushant V. Sahani, Kathleen M. Schmeler, Girish Shroff, Arlene O Siefker-Radtke, Elainea N. Smith, R. Jason Stafford, David J. Stewart, Chad D. Strange, Stephen G. Swisher, Ahmed Taher, Cher Heng Tan, Mylene T. Truong, Naoto T. Ueno, Gauri R. Varadhachary, Aradhana M. Venkatesan, Claire F. Verschraegen, Raghunandan Vikram, Sarah J.Vinnicombe, Mayur K. Virarkar, Chitra Viswanathan, Jason R. Westin, Wendy A. Woodward, T. Kuan Yu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::28a5c8227639b2784debc675d001af69
https://doi.org/10.1016/b978-0-323-69538-1.00047-1